Laboratory members



Research interests

Anna Wu

Akinyemi O. Oni-Orisan, PharmD, PhD

Principal Investigator

[email protected]

X Profile (formerly Twitter): @Akinyemi_OO

Introduction: Brains and Braggadocio (audio, 50 minutes).

Pronouns: he/him/his

Clinical validation of pharmacogenetic associations for cardiovascular therapies.


Anita Chaphekar, DO

Clinical Fellow

[email protected]

Fellow Perspective: Anita Chaphekar on Finding Your Medical Passion

Pronouns: she/her/hers

Optimizing real-world health data and electronic medical records to evaluate pharmacologic dosing regimens in pediatric and adolescent populations.


Michael Douglas, MS

Program Manager

[email protected]

X Profile (formerly Twitter): @MDouglas_MS

Pronouns: he/him/his

Evaluating the equitable implementation of new technologies in precision medicine for cardiovascular disease, cancer, and pharmacogenomics.


Tanushree Haldar, PhD

Data Scientist

[email protected]

Pronouns: she/her/hers

Implementing statistical methods in both local and cloud computing platforms to analyze biomedical data with special emphasis on pharmacogenomics and genetic epidemiology.


Joseph Harmon, BS

Research Associate

[email protected]

Pronouns: he/him/his

Analyzing the pharmacokinetics and pharmacodynamics of relevant medications using patient biospecimens, self-reported surveys, and electronic health records.


Mark Kvale, PhD

Programmer/Analyst (part-time)

[email protected]

Pronouns: he/him/his

Using statistical genetics and machine learning techniques to analyze data, to infer results in large-scale genetic and genomic experiments, and to develop novel approaches to analysis.


James Najera, MS

PhD Student in Epidemiology and Translational Science

[email protected]

Pronouns: he/him/his

Using population genetics, gene-environment interaction, and integration of omics for big data analytics. As a doctoral student, I aim to address health disparities among underrepresented communities in the field of genomic research.


Photo Name, Role, Years   Project Now

Janille Miranda, PharmD

Intensive Research Project

PharmD student


  Candidate genetic variants of statin-induced myotoxicity. PGY-1 pharmacy resident, Stanford University.

Mari Cayabyab, PharmD

Clinical Pharmacology and Therapeutics (CPT) postdoctoral fellow



Coronary heart disease polygenic risk score and secondary prevention of myocardial infarction.

Abstract/Award: Cayabyab et al. Clin Pharmacol Ther. 2022;111: S63. Jason Morrow Trainee Award winner (2nd-best trainee abstract at the conference).

Clinical pharmacy specialist – pharmacogenomics, University of Pennsylvania.

Siem Tsegay

Summer Student Research Program (SSRP) undergraduate student


  Pilot study to characterize the pharmacokinetics (PK) and pharmacodynamics (PD) of tamsulosin deprescribing Undergraduate student, Macalester College.

Brian Lu, PharmD

Pharmacogenomics Discovery Project PharmD student



Effect of SLCO1B1 T521C on statin-related myotoxicity with use of lovastatin and atorvastatin.

Publication: Lu et al. Clin Pharmacol Ther. 2021 Sep;110(3):733-740. PMID: 34114646.

PGY-2 infectious diseases pharmacy resident, Stanford University.